Scientists Unveil New Treatment Strategy That Could Outsmart Cancer

A new study suggests switching cancer drugs before tumors become resistant may work better than waiting for relapse.

Researchers used evolutionary and mathematical models to argue for changing therapy while the tumor is still shrinking.

The approach, called a kind of “two-strike” strategy, is being tested in small clinical trials.

If confirmed, earlier treatment switching could help doctors stay ahead of resistance and improve outcomes.